Business Context and Reporting Period
Company: CorVel Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2010
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation and auto policies. The company operates in one reportable segment: managed care, offering network solutions and patient management services to insurance companies, third-party administrators (TPAs), and self-insured employers.
Key Financial Metrics
| Metric (Nine Months Ended Dec 31) | 2010 | 2009 |
|---|---|---|
| Revenues | $280.2 million | $250.4 million |
| Net Income | $22.0 million | $19.5 million |
| Diluted EPS | $1.82 | $1.52 |
| Gross Margin | 25.3% | 25.5% |
| Operating Cash Flow | $38.2 million | $26.2 million |
| Cash and Equivalents (Dec 31, 2010) | $10.2 million | $15.8 million (Mar 31, 2010) |
| Debt | $0 (No outstanding revolving loans) | $0 |
Note: Cash and equivalents decreased from $15.8 million at the start of the fiscal year to $10.2 million at period end, primarily due to share repurchases and capital expenditures.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 11.9% year-over-year for the nine-month period, driven by a 20.0% increase in patient management services (specifically TPA services) and a 5.6% increase in network solutions (pharmacy and directed care).
- Profitability: Net income rose 13.0% to $22.0 million. Diluted EPS increased 19.7% to $1.82, aided by a reduction in the weighted average share count due to stock buybacks.
- Expense Increases: General and administrative (G&A) expenses rose 21.4% to $38.1 million. This was largely due to a $2.8 million accrual for a legal settlement and increased systems costs for software development.
- Tax Provision: The effective tax rate decreased from 40% to 33% for the nine-month period, primarily due to the resolution of outstanding state tax issues resulting in a $1.8 million liability reduction.
- Share Repurchases: The company repurchased 556,185 shares for $22.8 million during the nine-month period.
Guidance, Outlook, Risks, and Unusual Items
- Legal Settlement (Unusual Item): The company accrued $2.8 million in the prior quarter (Q3) for a class action settlement regarding PPO network referrals and billing software. The settlement was approved by the court in January 2011. The company denies liability.
- Pending Litigation: A class action arbitration regarding Louisiana's "Any Willing Provider Act" remains pending. The company is challenging the constitutionality of the act's damage provision. No loss amount can be estimated at this time.
- Outlook: Management expects future effective tax rates to return to the 38-40% range. The company anticipates continued investment in software capabilities for bill review and claims administration.
- Liquidity: The company maintains a $10 million revolving credit facility with no outstanding borrowings. Management believes cash from operations and the credit facility are sufficient to fund operations and share repurchases for the next 12 months.
- Risks: Key risks include declining workers' compensation claims due to economic conditions, increased competition, regulatory changes in healthcare, and potential liability from litigation.
Investor Verification Checklist
- Legal Accruals: Verify the final payout status of the $2.8 million Illinois class action settlement and monitor the status of the Louisiana arbitration.
- Margin Pressure: Monitor gross margins as the company shifts toward lower-margin TPA and pharmacy services, which drove revenue growth but increased cost of revenue.
- Share Count: Confirm the impact of ongoing share repurchases on future EPS, noting the company has repurchased 55% of outstanding shares historically.
- Software Investment: Track the return on investment for increased capital expenditures in software development and systems costs.
- Effective Tax Rate: Watch for the normalization of the effective tax rate back to the 38-40% range in future quarters.